Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | PARP1 | P09874 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9199075 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNASLC18A3MEN1KMT2A | |
| SCHEMBL9199080 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNASLC18A3MEN1KMT2A | |
| SCHEMBL9367168 | 0.81 | SLC18A3 (0.49) | ALDH1A1SLC18A3PARP1OPRM1OPRD1 | |
| SCHEMBL9204631 | 0.81 | SLC18A3 (0.49) | ALDH1A1SLC18A3PARP1OPRM1OPRD1 | |
| SCHEMBL9367163 | 0.81 | SLC18A3 (0.49) | ALDH1A1SLC18A3PARP1OPRM1OPRD1 | |
| SCHEMBL9200937 | 0.80 | DRD2 (0.54) | ALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL9200941 | 0.80 | DRD2 (0.54) | ALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL9200935 | 0.80 | DRD2 (0.54) | ALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL9196288 | 0.73 | ALDH1A1 (0.56) | ALDH1A1MEN1KMT2APARP1 | |
| SCHEMBL9196291 | 0.73 | ALDH1A1 (0.56) | ALDH1A1MEN1KMT2APARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0431580-B1 | Substituted cyclohexanols as central nervous system agents | WARNER LAMBERT CO (US) | 1995-03-08 | — | — | EP | claimed |
| EP-0431580-A2 | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | claimed |
| EP-0431580-B1 | Substituted cyclohexanols as central nervous system agents | WARNER LAMBERT CO (US) | 1995-03-08 | — | — | EP | disclosed |
| US-5047406-A | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT CO. (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0431580-A2 | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | disclosed |
| US-4957921-A | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1990-09-18 | — | — | US | disclosed |